论文部分内容阅读
为进一步探讨该疗法的作用机制及意义,我们观察了该疗法治疗慢乙肝患者前、后自然杀伤细胞(NK细胞)活性及白细胞介素Ⅱ受体(IL-2R)阳性细胞数,报道如下。1 材料与方法1.1 对象 慢乙肝患者29例,按1995年第五次全国传染病寄生虫病学术会议修订的病毒性肝炎诊断标准,均为慢性中度活动患者。1年内未使用过免疫制剂,全部为男性,年龄21～51岁,平均35岁,对照组14例,男8例,女6例,年龄19～52岁,平均28岁,乙肝病毒血清标志物均阴性。
To further explore the mechanism and significance of this therapy, we observed the natural killer (NK) cell activity and the number of interleukin 2 receptor (IL-2R) -positive cells before and after treatment of chronic hepatitis B patients. 1 Materials and Methods 1.1 Subjects 29 patients with chronic hepatitis B, according to the 1995 Fifth National Conference on Infectious Diseases Parasitic Diseases revised diagnostic criteria for viral hepatitis, are chronic moderate activity in patients. 1 year unused immune agents, all male, aged 21 to 51 years old, with an average of 35 years old, the control group of 14 patients, 8 males and 6 females, aged 19 to 52 years, mean 28 years old, hepatitis B virus serum markers All negative.